Sigma Healthcare Ltd SIG
ASX · Australia · Health Technology
AUD 2.60+0.03 (+0.97%)
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Private equity owner Sycamore is reportedly in advanced talks over the sale, only a year after taking over Boots.
Foreign investors have poured a record US$942b into US equities over 12 months, which leaves plenty of global money hunting for the next pocket of value. That spotlight often shifts to Australian businesses with strong cash generation and resilient balance sheets that trade below what careful analysis suggests they are worth. This article highlights three such high quality but underpriced Australian stocks from our value-focused screener. The three stocks below are just a starting sample from...
Sigma Healthcare Ltd (SIGGF) delivers record FY26 results with normalized EBIT up over 20% and Chemist Warehouse network sales hitting $10.2 billion milestone.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.